Anti-ACE2 (Intermediate Domain) - 0.1 mg

ELISA, IF, IHC FFPE, WB

ACE2

Next Day Ambient

Angiotensin I converting enzyme 2 (ACE2) is an exopeptidase that catalyses the conversion of angiotensin I to the nonapeptide angiotensin, or the conversion of angiotensin II to angiotensin. ACE 2 has direct effects on cardiac function, and is expressed predominantly in vascular endothelial cells of the heart and the kidneys. ACE2 plays a regulatory role in lung pathophysiology, including pulmonary fibrosis and acute lung disease. Activation of ACE2 by a small molecule can be a therapeutically relevant approach for treating and controlling Pulmonary Hypertension (PH). ACE2 may also have clinical potential as a novel molecular target for the treatment of pancreatic ductal adenocarcinoma (PDAC).

ACE2

Rabbit Anti-Human Angiotensin-Converting Enzyme 2 (ACE2) recognizes an epitope in the intermediate domain of Human ACE2. This polyclonal antibody was purified using affinity chromatography.

0.5 mg/ml

ACE2 antibody was raised against a synthetic peptide corresponding to amino acids near the center of human ACE2. The immunogen is located within amino acids 150 - 200 of ACE2.

Polyclonal Antibody, Angiotensin-Converting Enzyme 2, ACEH, ACE2, Human, Anti-Human Angiotensin-Converting Enzyme 2 (Intermediate Domain 2), ACE2 Antibody, ACEH, Angiotensin-converting enzyme 2, ACE-related carboxypeptidase, ACEH, SARS-CoV-2 receptor, COVID-19